Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.03.235291Source: DataRank Database

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (33)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

F. Forouhar ORCID,Hengrui Liu ORCID,Seo Jung Hong,Fang‐Yu Lin ORCID,Manoj S. Nair ORCID

Live enrichment

PubMed:32793898 OpenAlex:https://openalex.org/W3047366796

National Science Foundation

Grant: 2029943

RAPID Enhanced SARS-CoV-2 High-Throughput Crystallization for Structural Studies

National Institutes of Health

Grant: 2T32AI106711-06A1

Columbia University Graduate Training Program in Microbiology and Immunology

National Institutes of Health

Grant: 3P30GM124165-03S1

NE-CAT: A Resource for Advanced Macromolecular Crystallography

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/08/04/2020.08.03.235291.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.08.03.235291

repositoryhttps://doi.org/10.1101/2020.08.03.235291

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32793898

Fields of Study

SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsRNA and protein synthesis mechanisms0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

ProteaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakIdentification (biology)VirologyComputational biologyChemistryEnzymeBiologyMedicineBiochemistryEcologyPyrrolidinesLactamsSARS-CoV-2ScienceQDrug Evaluation, PreclinicalCrystallography, X-RayVirus ReplicationArticleCOVID-19 Drug TreatmentLeucineHumansSulfonic AcidsCoronavirus 3C Proteases

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health